⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2306121 | 0.90 | CYP2C19 (0.52) | — | |
| SCHEMBL8437124 | 0.88 | CYP2C19 (0.56) | — | |
| SCHEMBL16500063 | 0.81 | CYP2C19 (0.40) | — | |
| SCHEMBL10176442 | 0.77 | — | — | |
| SCHEMBL517571 | 0.77 | — | — | |
| SCHEMBL11664080 | 0.77 | CYP2C19 (0.38) | — | |
| SCHEMBL23803960 | 0.73 | CYP2C19 (0.35) | — | |
| SCHEMBL17033330 | 0.72 | CYP4F2 (0.46) | — | |
| SCHEMBL1652739 | 0.71 | CYP2C19 (0.40) | — | |
| Formamide SCHEMBL28846872 | 0.70 | CYP2C19 (0.37) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11130750-B2 | Calcium channel inhibitors | CAVION, INC. (US) | 2021-09-28 | — | — | US | disclosed |
| US-20200385367-A1 | CALCIUM CHANNEL INHIBITORS | CAVION, INC. | 2020-12-10 | — | — | US | disclosed |
| CN-110214133-A | N- { [2- (piperidin-1-yl) phenyl ] (phenyl) methyl } -2- (3-oxo-3, 4-dihydro-2H-1, 4-benzoxazin-7-yl) acetamide derivatives and related compounds as ROR γ modulators for the treatment of autoimmune diseases | 基恩菲特公司 | 2019-09-06 | — | — | CN | disclosed |
| CN-108368107-A | FUSED HETEROCYCLIC COMPOUNDS AS S1P MODULATORS | 艾伯维公司 | 2018-08-03 | — | — | CN | disclosed |
| EP-2491022-B1 | DIAZEPAN DERIVATIVES AS MODULATORS OF CHEMOKINE RECEPTORS | HOFFMANN LA ROCHE (CH) | 2014-12-31 | — | — | EP | disclosed |
| US-8642592-B2 | Oxo-heterocyclically substituted alkyl carboxylic acids and use thereof | BAYER INTELLECTUAL PROPERTY GMBH (DE) | 2014-02-04 | — | — | US | disclosed |
| US-20120028971-A1 | OXO-HETEROCYCLICALLY SUBSTITUTED ALKYL CARBOXYLIC ACIDS AND USE THEREOF | BAYER PHARMA AKTIENGESELLSCHAFT (DE) | 2012-02-02 | — | — | US | disclosed |
| CN-102089289-A | Novel heterocyclyl compounds for treatment of cardiovascular disease | HOFFMANN LA ROCHE | 2011-06-08 | — | — | CN | disclosed |
| WO-2009010429-A2 | NOVEL HETEROCYCLYL COMPOUNDS AND THEIR USE AS CHEMOKINE ANTAGONISTS | F. HOFFMANN-LA ROCHE AG (CH) | 2009-01-22 | — | — | WO | disclosed |